![](https://pharmashots.com/public/default-image/default-730x400.png )
PharmaShots Weekly Snapshots (July 15 – July 19, 2024)
This week PharmaShots’ news was all about the updates on Clinical Trials, Pharma, Biotech, COVID-19, Regulatory & MedTech. Check out our full report below:
Camurus Reports the P-III (ACROINNOVA 2) Trial Data of Octreotide SC Depot (CAM2029) for Treating Acromegaly
Read More: Camurus
Lexeo Therapeutics Reports Interim Data from P-I/II Study of LX2006 to Treat Friedreich Ataxia Cardiomyopathy
Read More: Lexeo Therapeutica
Roche Reports the P-I (CT-996-201) Study Data of CT-996 for Treating Obesity
Read More: Roche
Bayer Provides Update on P-III (ARANOTE) Study of Darolutamide to Treat Metastatic Hormone-Sensitive Prostate Cancer
Read More: Bayer
Sanofi Publishes the P-III (XTEND-Kids) Study Data of Altuviiio to Treat Children with Severe Hemophilia A in the NEJM
Read More: Sanofi
Bionomics Reports the Commencement of P-III (AFFIRM-1) Study Evaluating BNC210 for Social Anxiety Disorder (SAD)
Read More: Bionomics
Roche Reports the P-III (RHONE-X) Study Data of Vabysmo for the Treatment of Diabetic Macular Edema (DME)
Read More: Roche
AbbVie Reports the Regulatory Submissions to the US FDA and EMA of Rinvoq (Upadacitinib) to Treat Giant Cell Arteritis (GCA)
Read More: AbbVie
Arrivo BioVentures’ RABI-767 Receives the US FDA’s Fast Track Designation for Treating Acute Pancreatitis
Read More: Arrivo BioVentures
Zai Lab and argenx Report the NMPA’s Approval of Efgartigimod Alfa SC Injection to Treat Generalized Myasthenia Gravis
Read More: Zai Lab & argenx
MindMed Receives US Patent for MM120 to Treat Generalized Anxiety Disorder
Read More: MindMed
Atara Biotherapeutics Reports the US FDA’s BLA Acceptance with Priority Review of Tabelecleucel to Treat Post-Transplant Lymphoproliferative Disease
Read More: Atara Biotherapeutics
Ono Pharmaceutical Reports the EMA’s Acceptance of MAA for Vimseltinib to Treat Tenosynovial Giant Cell Tumor (TGCT)
Read More: Ono Pharmaceutical
Phathom Pharmaceuticals’ Voquezna Receives the US FDA’s Approval for Relieving Heartburn Associated with Non-Erosive GERD
Read More: Phathom Pharmaceuticals
GSK Reports the EMA’s Acceptance of MAA for Blenrep Combinations to Treat Multiple Myeloma
Read More: GSK
BMS Reports the EMA’s Validation of Application for Opdivo Plus Yervoy to Treat Hepatocellular Carcinoma
Read More: BMS
Nona Biosciences Partners with Alaya.bio to Advance CAR-T Cell Therapy
Read More: Nona Biosciences & Alaya.bio
Enveric Biosciences Collaborates with Aries Science & Technology to Develop its Dermatitis Topical Product
Read More: Enveric Biosciences & Aries Science & Technology
SOTIO Biotech Collaborates with Biocytogen for Expanding ADC Pipeline
Read More: SOTIO Biotech
Orum Therapeutics Collaborates with Vertex Pharmaceuticals for the Development of Degrader-Antibody Conjugates
Read More: Orum & Vertex
SK Biopharmaceuticals Teams Up with Full-Life Technologies to Develop FL-091 for Multiple Solid Tumors
Read More: SK Biopharmaceuticals & Full-Life Technologies
Meitheal Acquires Rights of Nabriva’s Contepo, Expanding its Specialty Biopharmaceuticals Portfolio
Read More: Meitheal & Nabriva
Oticon Medical Reports the US FDA’s Clearance of its Bone Conduction Hearing System
Read More: Oticon Medical
NextStep Arthropedix to Introduce TheRay Hip System
Read More: NextStep Arthropedix
Globus Medical Reports the US FDA’s Clearance of ExcelsiusFlex and ACTIFY 3D Total Knee Systems
Read More: Globus Medical
Lantheus Strengthens its Alzheimer’s Disease Pipeline Through the Acquisition of Meilleur Technologies
Read More: Lantheus Strenthens & Meilleur Technologies
GE HealthCare to Expand its AI-Based Portfolio Through the Acquisition of Intelligent Ultrasound’s Business Unit
Read More: GE HealthCare & Intelligent Ultrasound
Dechra Pharmaceuticals to Acquire Invetx, Expanding its Monoclonal Antibody Portfolio for Companion Animals
Read More: Dechra Pharmaceuticals & Invetx
PetPace Reports the Availability of its AI-Based Pet Health Monitoring Collar Across Canada
Read More: PetPace
Subtle Medical’s AI-Based Synthetic Imaging Software Gains the US FDA’s Clearance
Read More: Subtle Medical
Related Post: PharmaShots Weekly Snapshots (July 08 – July 12, 2024)
Tags
![](https://pharmashots.com/public/images/Disha-2023-03-21-64199f99761c8.png)
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.